AUHardball
07-23-2007, 11:00 PM
AVVAA WORLD HEALTH CARE
O/S: 250,194,198
Market Cap: 225,175
Avvaa World Health Care Prod. (OTC BB: AVVW)
avVaa World Health Care Products Commences Marketing in the $4 Billion Over-the-Counter Skin Care Market
avVaa World Health Care Products Inc. (OTC Bulletin Board: AVVW.OB), a global biotechnology company offering therapeutic, 98% natural skin and health care products, announced today that it has commenced marketing brochures for NEUROSKIN to Over-the-Counter retailers and drug stores in North America. NEUROSKIN(R) targets the over 40 million North Americans who suffer from skin related problems and spend nearly $4 billion annually on OTC product treatments.
See the brochures in full color online at www.avvaa.com for the following products: NEUROSKIN(R) Psoriasis Relief OTC Product; NEUROSKIN(R) Acne Treatment OTC Product; NEUROSKIN(R) Itch Relief OTC Product; and NEUROSKIN(R) Mild Skin Moisturizer Cosmetic Product.
Lorie Campbell-Farley, EVP Sales & Marketing of avVaa, said, "Relief from multiple chronic skin conditions has arrived. Our products are now available, without a prescription, at your local drug store. Increasing our products availability, supported by our ongoing marketing efforts, enables avVaa to start spreading the news that relief has arrived for the millions who currently suffer from psoriasis, seborrheic dermatitis and acne." About avVaa World Health Care Products avVaa World Health Care Products (OTC Bulletin Board: AVVW.OB) is a global biotechnology company that specializes in effective, all natural, steroid-free therapeutic skin care products that improve the quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, OTC-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including dermatitis, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.
The Company's second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ animal care and products market in the USA. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.
I just copied this from stockhouse!
O/S: 250,194,198
Market Cap: 225,175
Avvaa World Health Care Prod. (OTC BB: AVVW)
avVaa World Health Care Products Commences Marketing in the $4 Billion Over-the-Counter Skin Care Market
avVaa World Health Care Products Inc. (OTC Bulletin Board: AVVW.OB), a global biotechnology company offering therapeutic, 98% natural skin and health care products, announced today that it has commenced marketing brochures for NEUROSKIN to Over-the-Counter retailers and drug stores in North America. NEUROSKIN(R) targets the over 40 million North Americans who suffer from skin related problems and spend nearly $4 billion annually on OTC product treatments.
See the brochures in full color online at www.avvaa.com for the following products: NEUROSKIN(R) Psoriasis Relief OTC Product; NEUROSKIN(R) Acne Treatment OTC Product; NEUROSKIN(R) Itch Relief OTC Product; and NEUROSKIN(R) Mild Skin Moisturizer Cosmetic Product.
Lorie Campbell-Farley, EVP Sales & Marketing of avVaa, said, "Relief from multiple chronic skin conditions has arrived. Our products are now available, without a prescription, at your local drug store. Increasing our products availability, supported by our ongoing marketing efforts, enables avVaa to start spreading the news that relief has arrived for the millions who currently suffer from psoriasis, seborrheic dermatitis and acne." About avVaa World Health Care Products avVaa World Health Care Products (OTC Bulletin Board: AVVW.OB) is a global biotechnology company that specializes in effective, all natural, steroid-free therapeutic skin care products that improve the quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, OTC-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including dermatitis, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.
The Company's second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ animal care and products market in the USA. avVaa sells its quality Animal Care products through partnerships with established distributors and retailers in both Canada and the United States.
I just copied this from stockhouse!